Terms: = Ovarian cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM
58 results:
1. Derivation and validation of a nomogram based on clinical characteristics to diagnose endometriosis associated ovarian cancer preoperatively.
Xu T; Nie X; Zhang L; Meng H; Jiang Y; Wan Y; Cheng W
J Cancer Res Clin Oncol; 2024 Jan; 150(1):19. PubMed ID: 38243112
[TBL] [Abstract] [Full Text] [Related]
2. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.
Newhouse R; Nelissen E; El-Shakankery KH; Rogozińska E; Bain E; Veiga S; Morrison J
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD006910. PubMed ID: 37407274
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of apatinib combined with liposomal doxorubicin or paclitaxel versus liposomal doxorubicin or paclitaxel monotherapy in patients with recurrent platinum-resistant ovarian cancer.
Yang H; Geng A; Wang Z; Wu C
J Obstet Gynaecol Res; 2023 Jun; 49(6):1611-1619. PubMed ID: 36988159
[TBL] [Abstract] [Full Text] [Related]
4. Villin expression in human tumors: a tissue microarray study on 14,398 tumors.
Dum D; Lennartz M; Menz A; Kluth M; Hube-Magg C; Weidemann S; Fraune C; Luebke AM; Hornsteiner L; Bernreuther C; Simon R; Clauditz TS; Sauter G; Uhlig R; Hinsch A; Kind S; Jacobsen F; Möller K; Wilczak W; Steurer S; Minner S; Burandt E; Marx AH; Krech T; Lebok P
Expert Rev Mol Diagn; 2022 Jun; 22(6):665-675. PubMed ID: 35866621
[TBL] [Abstract] [Full Text] [Related]
5. Weight-change trajectory in relation to cancer risk: findings from a nationwide cohort study in South Korea.
Tran TPT; Luu NM; Bui TT; Han M; Lim MK; Oh JK
Obesity (Silver Spring); 2022 Jul; 30(7):1507-1519. PubMed ID: 35785482
[TBL] [Abstract] [Full Text] [Related]
6. Sarcopenia as an Independent Risk Factor for Specific cancers: A Propensity Score-Matched Asian Population-Based Cohort Study.
Sun MY; Chang CL; Lu CY; Wu SY; Zhang JQ
Nutrients; 2022 May; 14(9):. PubMed ID: 35565877
[TBL] [Abstract] [Full Text] [Related]
7. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM
Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165
[TBL] [Abstract] [Full Text] [Related]
8. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.
Dum D; Menz A; Völkel C; De Wispelaere N; Hinsch A; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T
Exp Mol Pathol; 2022 Jun; 126():104762. PubMed ID: 35390310
[TBL] [Abstract] [Full Text] [Related]
9. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
[No Abstract] [Full Text] [Related]
10. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples.
Jansen K; Farahi N; Büscheck F; Lennartz M; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Clauditz T; Bernreuther C; Dum D; Krech T; Marx A; Steurer S
Pathol Res Pract; 2021 Dec; 228():153663. PubMed ID: 34717148
[TBL] [Abstract] [Full Text] [Related]
11. Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.
Zhang T; Zheng YY; Yang ZR; Shi Q; Wang XS; Zhao J; Yang M; Wu CL; Wang GR
BMC Womens Health; 2021 Jul; 21(1):276. PubMed ID: 34325677
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors.
Menz A; Bauer R; Kluth M; Marie von Bargen C; Gorbokon N; Viehweger F; Lennartz M; Völkl C; Fraune C; Uhlig R; Hube-Magg C; De Wispelaere N; Minner S; Sauter G; Kind S; Simon R; Burandt E; Clauditz T; Lebok P; Jacobsen F; Steurer S; Wilczak W; Krech T; Marx AH; Bernreuther C
Hum Pathol; 2021 Sep; 115():19-36. PubMed ID: 34102222
[TBL] [Abstract] [Full Text] [Related]
13. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.
Yan S; Fang J; Chen Y; Xie Y; Zhang S; Zhu X; Fang F
BMC Cancer; 2020 Dec; 20(1):1205. PubMed ID: 33287740
[TBL] [Abstract] [Full Text] [Related]
16. Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer.
Dackus GMHE; Jóźwiak K; van der Wall E; van Diest PJ; Hauptmann M; Siesling S; Sonke GS; Linn SC
Breast Cancer Res Treat; 2021 Feb; 185(3):817-830. PubMed ID: 33113088
[TBL] [Abstract] [Full Text] [Related]
17. Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation.
Fadadu PP; Polen-De CL; McGree ME; Weaver AL; Moynagh MR; Takahashi N; Langstraat CL; Cliby WA; Kumar A
Gynecol Oncol; 2021 Jan; 160(1):40-44. PubMed ID: 33109391
[TBL] [Abstract] [Full Text] [Related]
18. ovarian Sparing Surgery in Mature ovarian Teratomas in Children: A 20-Year Single-Center Experience.
Szymon O; Bogusz B; Taczanowska-Niemczuk A; Maślanka M; Górecki W
Eur J Pediatr Surg; 2021 Feb; 31(1):2-7. PubMed ID: 32950035
[TBL] [Abstract] [Full Text] [Related]
19. Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.
Olafsdottir EJ; Borg A; Jensen MB; Gerdes AM; Johansson ALV; Barkardottir RB; Johannsson OT; Ejlertsen B; Sønderstrup IMH; Hovig E; Lænkholm AV; Hansen TVO; Olafsdottir GH; Rossing M; Jonasson JG; Sigurdsson S; Loman N; Nilsson MP; Narod SA; Tryggvadottir L
Br J Cancer; 2020 Nov; 123(11):1608-1615. PubMed ID: 32939053
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis, biological evaluation and virtual screening of some acridone derivatives as potential anticancer agents.
Oyedele AS; Bogan DN; Okoro CO
Bioorg Med Chem; 2020 May; 28(9):115426. PubMed ID: 32201193
[TBL] [Abstract] [Full Text] [Related]
[Next]
